BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 17959745)

  • 1. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.
    Anderson DJ; Bunnelle W; Surber B; Du J; Surowy C; Tribollet E; Marguerat A; Bertrand D; Gopalakrishnan M
    J Pharmacol Exp Ther; 2008 Jan; 324(1):179-87. PubMed ID: 17959745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic acetylcholine receptor antagonists alter the function and expression of serine racemase in PC-12 and 1321N1 cells.
    Singh NS; Paul RK; Ramamoorthy A; Torjman MC; Moaddel R; Bernier M; Wainer IW
    Cell Signal; 2013 Dec; 25(12):2634-45. PubMed ID: 24012499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors.
    Horti AG; Ravert HT; Gao Y; Holt DP; Bunnelle WH; Schrimpf MR; Li T; Ji J; Valentine H; Scheffel U; Kuwabara H; Wong DF; Dannals RF
    Nucl Med Biol; 2013 Apr; 40(3):395-402. PubMed ID: 23294899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dinoflagellate Toxin 20-Methyl Spirolide-G Potently Blocks Skeletal Muscle and Neuronal Nicotinic Acetylcholine Receptors.
    Couesnon A; Aráoz R; Iorga BI; Benoit E; Reynaud M; Servent D; Molgó J
    Toxins (Basel); 2016 Aug; 8(9):. PubMed ID: 27563924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents.
    Orr-Urtreger A; Göldner FM; Saeki M; Lorenzo I; Goldberg L; De Biasi M; Dani JA; Patrick JW; Beaudet AL
    J Neurosci; 1997 Dec; 17(23):9165-71. PubMed ID: 9364063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Evaluation of Compound Targeting α7 and β2 Subunits in Nicotinic Acetylcholinergic Receptor.
    Singh K; Ngo A; Keerthisinghe OV; Patel KK; Liang C; Mukherjee J
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of α7 nicotinic acetylcholine receptor agonist against α-synuclein-induced neurotoxicity.
    Takizawa S; Ohuchi K; Fujimaki A; Ito T; Murakami T; Kurita H; Inden M
    Neurosci Lett; 2024 Feb; 823():137654. PubMed ID: 38281695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs.
    Eibl C; Munoz L; Tomassoli I; Stokes C; Papke RL; Gündisch D
    Bioorg Med Chem; 2013 Dec; 21(23):7309-29. PubMed ID: 24145137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel alpha7 nicotinic receptor antagonists.
    Peng Y; Zhang Q; Snyder GL; Zhu H; Yao W; Tomesch J; Papke RL; O'Callaghan JP; Welsh WJ; Wennogle LP
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4825-30. PubMed ID: 20638843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.
    Zheng G; Sumithran SP; Deaciuc AG; Dwoskin LP; Crooks PA
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6701-6. PubMed ID: 17977723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nicotinic receptor-mediated anti-inflammatory effect of the flavonoid rhamnetin in BV2 microglia.
    Lutz JA; Kulshrestha M; Rogers DT; Littleton JM
    Fitoterapia; 2014 Oct; 98():11-21. PubMed ID: 24972350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold.
    Dallanoce C; Richter K; Stokes C; Papotto C; Andleeb H; Thakur GA; Kerr A; Grau V; Papke RL
    ACS Chem Neurosci; 2024 Feb; 15(4):827-843. PubMed ID: 38335726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of tritiated JNJ-GluN2B-5 (3-[
    Schoellerman J; Lord B; Bhattacharya A; Stenne B; Wall JL; Rech J; Letavic M; Bonaventure P; Balana B
    J Neurochem; 2024 May; ():. PubMed ID: 38770633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational neural network analysis of the affinity of N-n-alkylnicotinium salts for the alpha4beta2* nicotinic acetylcholine receptor.
    Zheng F; Zheng G; Deaciuc AG; Zhan CG; Dwoskin LP; Crooks PA
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):157-68. PubMed ID: 18629679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [
    Donat CK; Hansen HH; Hansen HD; Mease RC; Horti AG; Pomper MG; L'Estrade ET; Herth MM; Peters D; Knudsen GM; Mikkelsen JD
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32245032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of (1
    Britvin SN; Rumyantsev AM
    Acta Crystallogr E Crystallogr Commun; 2017 Dec; 73(Pt 12):1861-1865. PubMed ID: 29250403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of Nicotinic Acetylcholine Receptor Positive Allosteric Modulators Revealed by Mutagenesis and a Revised Structural Model.
    Newcombe J; Chatzidaki A; Sheppard TD; Topf M; Millar NS
    Mol Pharmacol; 2018 Feb; 93(2):128-140. PubMed ID: 29196491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of α
    Hillmer AT; Li S; Zheng MQ; Scheunemann M; Lin SF; Nabulsi N; Holden D; Pracitto R; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Esterlis I; Cosgrove KP; Brust P; Carson RE; Huang Y
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1042-1050. PubMed ID: 28120003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia.
    Bristow LJ; Easton AE; Li YW; Sivarao DV; Lidge R; Jones KM; Post-Munson D; Daly C; Lodge NJ; Gallagher L; Molski T; Pieschl R; Chen P; Hendricson A; Westphal R; Cook J; Iwuagwu C; Morgan D; Benitex Y; King D; Macor JE; Zaczek R; Olson R
    PLoS One; 2016; 11(7):e0159996. PubMed ID: 27467081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.
    Beinat C; Banister SD; Herrera M; Law V; Kassiou M
    CNS Drugs; 2015 Jul; 29(7):529-42. PubMed ID: 26242477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.